Topical Minoxidil for Hair Regrowth - Quick Reference Sheet

Topical Minoxidil for Hair Regrowth

Created on 08/01/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

A scalp-applied, non-prescription drug that modestly slows pattern hair loss and regrows hair in men and women. It works best on early thinning and does little on bald or scarred areas. Results come slowly and last only with continued daily use; some people do not respond. Side effects are mainly scalp irritation and occasional unwanted facial hair. (Full Review)

Protocol

Dose
Men 5%; Women 2% or 5% foam
Solution twice daily; foam once daily
Application
Apply to dry scalp
Minimum effective volume; let dry fully; wash hands
Consistency
Daily, indefinite use
Consistency matters more than time of day
Time to effect
Regrowth begins
3–6 months
First visible new growth
Full assessment
12 months
Gains plateau by about one year
Less shedding
2–4 months
Daily shedding trends down

Benefits

Contraindications
  • Pregnancy and breastfeeding
  • Children under 18
  • Cardiovascular disease (recent heart attack, uncontrolled arrhythmia, advanced heart failure NYHA III–IV)
  • Pheochromocytoma
  • Active, broken, or infected scalp skin
Key Interactions
  • Prescription antihypertensives and vasodilators (guanethidine, minoxidil tablets)
  • Penetration-enhancing topicals (tretinoin, retinoids, anthralin, corticosteroids)
  • Barrier-disrupting over-the-counter topicals (salicylic acid, exfoliants)
  • Blood-pressure-lowering supplements (high-dose arginine)
  • Microneedling

Risk & Side Effects

  • High: Scalp irritation and contact dermatitis; initial increased shedding
  • Medium: Unwanted facial or body hair growth; loss of efficacy on discontinuation
  • Low: Systemic cardiovascular effects; allergic contact dermatitis
  • Speculative: Inadvertent transfer to children or pets

Monitoring

Marker Target Why
Ferritin (iron stores) 40–70 ng/mL Low iron blunts regrowth and drives its own shedding
TSH 1.0–2.0 mIU/L Thyroid dysfunction causes diffuse thinning that mimics or worsens pattern loss
Vitamin D (25-OH) 40–60 ng/mL Low status is linked to hair-cycle disruption and poorer follicle health
Resting heart rate 50–70 bpm Detects the rare tachycardia from systemic absorption
Blood pressure <120/80 mmHg Screens for the rare systemic vasodilator effect

Cadence: Reassess with photographs and self-report at ~4 months, 6 months, then every 6–12 months

Qualitative Assessment

  • Daily shedding trending down after the early surge
  • Visible density and scalp show-through in consistent lighting and camera angles
  • Hair-shaft feel and thickness (finer hairs maturing into thicker hairs)
  • Absence of persistent scalp itch, redness, or flaking
  • No new facial or body hair, swelling, lightheadedness, or racing heartbeat